Planta Med 2000; 66(5): 444-447
DOI: 10.1055/s-2000-8599
Original Paper
Georg Thieme Verlag Stuttgart · New York

Oral Absorption and Bioavailability of Tea Catechins

Min Zhu1 , Yu Chen1 , Ronald C. Li1, 2
  • 1 Department of Pharmacy, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong
  • 2 Pharmacokinetic/Pharmacodynamic Sciences, Genetics Institute, Andover, Massachusetts, USA
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
31. Dezember 2000 (online)

Abstract

The absorption characteristics and oral bioavailability of three tea catechins, namely (-)-epicatechin (EC), (-)-epicatechin gallate (ECG), and (-)-epigallocatechin gallate (EGCG), were assessed in this study. Male Sprague Dawley rats (210 - 230 g) received either an intravenous (i.v. 50 mg/kg) or oral (5000 mg/kg) dose of decaffeinated catechin-fraction containing EC (5 %), EGCG (50 %), and ECG (13 %). Concentrations of the compounds in plasma, urine, and feces were measured using HPLC. A non-compartmental approach was employed for pharmacokinetic analysis. Results indicated that maximum plasma concentrations for the catechins (15 - 112 μg/ml) were achieved at 2 h post-oral dosing and the apparent volume of distribution (Vd/F) ranged from 30 to 63 l/kg. Absolute bioavailability (F) of EC, EGCG, and ECG was assessed to be 0.39, 0.14, and 0.06, respectively. Estimates of terminal elimination half-life (t1/2,λz) of the catechins after oral dosing were 451 - 479 min and were 1.4 - 10 fold longer than those observed for the i.v. dosing. The discrepancy in terminal elimination and low rate and extent of absorption indicated the possibility of flip-flop kinetics. Respective urinary recoveries were 0.17 - 4.72 % and 2.11 - 14.2 % after oral and i.v. dosing. In conclusion, the low systemic availability of tea catechins observed could be a result of slow absorption, high first pass effect, and wide tissue distribution.

References

  • 1 Weisburger  J H.. Tea and health: The underlying mechanisms.  Proceeding of the Society for Experimental Biology and Medicine. 1999;;  220 271-5
  • 2 Yamamoto  T.. Chemistry and Applications of Green Tea,. CRC Press, Boca Raton,; 1997
  • 3 Chen  L S,, Lee  M J,, Li  H,, Yang  C S.. Absorption, distribution and elimination of tea polyphenols in rats.  Drug Metabolism and Disposition. 1997;;  25 1045-50
  • 4 Van het Hof  K H,, Kivits  G AA,, Weststrate  J A,, Tijburg  L BM.. Bioavailability of catechins from tea: the effect of milk.  European Journal of Clinical Nutrition. 1998;;  52 356-9
  • 5 Okushio  K,, Matsumoto  N,, Kohri  T,, Suzuki  M.. Absorption of tea catechins into rat portal vein.  Biology and Pharmacology Bulletin. 1996;;  19 326-9
  • 6 Zhu  M,, Chen  Y,, Li  R C.. Pharmacokinetics of tea catechins.  Pharmaceutical Sciences, Supplement. 1999;;  4 3143
  • 7 Seto  R,, Nakamura  H,, Nanjo  F,, Hara  Y.. Preparation of epimers of tea catechins by heat treatment.  Bioscience, Biotechnology and Biochemistry. 1997;;  61 1434-9
  • 8 Lee  M J,, Wang  Z Y,, He  L,, Chen  L,, Yang  S,, Gobbo  S,, Balentine  D A,, Yang  C S.. Analysis of plasma and urinary tea polyphenols in human subjects.  Cancer Epidemiology Biomarkers and Prevention. 1995;;  4 393-9
  • 9 Haslam  E.. Natural polyphenols (vegetable tannins) as drugs: possible modes of action.  Journal of Natural Products. 1996;;  59 205-15
  • 10 Zhang  A,, Chan  P T,, Luk  Y S,, Ho  W KK,, Chen  Z Y.. Inhibitory effect of jasmine green tea epicatechin isomers on LDL-oxidation.  Nutritional Biochemistry. 1997;;  8 334-40
  • 11 Yang  C S,, Chen  L S,, Lee  M J,, Balentine  D,, Kuo  M C,, Schantz  S P.. Blood and urine levels of tea catechins after ingestion of different amount of green tea by human volunteers.  Cancer Epidemiology Biomarkers and Prevention. 1998;;  7 351-4

Dr. Ronald C. Li

Pharmacokinetic/Pharmacodynamic Sciences Genetics Institute

One Burtt Road

Andover

MA 01810

USA

eMail: rcli@genetics.com

Telefon: +1-978-247-1389